Blog Posts (21)
November 26, 2013
[Mother Jones]The European manufacturer of an emergency contraceptive pill identical to Plan B, also known as the morning-after pill, will warn women that the drug is completely ineffective for women who weigh more than 176 pounds and begins to lose ef...
November 21, 2013
[FiercePharma] Google made major waves two months ago when it landed former Genentech CEO Art Levinson to run its still-murky biotech offshoot, Calico. Now the biotech elder statesman is reuniting with his former chief medical officer, convincing Hal B...
November 20, 2013
[The Chronicle of Higher Education] Just days after federal prosecutors concluded one of the nation’s largest fraud settlements involving a single drug, at least some university researchers are retreating from a medical-journal article that helped se...
November 20, 2013
[Science Daily ] Almost one in three (29%) large clinical trials remain unpublished five years after completion. And of these, 78% have no results publicly available, finds a new study.This means that an estimated 250,000 people have been exposed to th...
November 19, 2013
Here is an article that I wrote for the Hastings Center Report describing the problem of missing and misleading information about our medicines and what to do about it.
Abstract. In 1971, President Richard Nixon declared a “war against cancer,
November 18, 2013
[Nature, Abstract] Drugs are approved by regulatory agencies on the basis of their assessment of whether the available evidence indicates that the benefits of the drug outweigh its risks. In recent years, regulatory agencies have been criticized both f...
November 2, 2013
[The Guardian] Almost a third of large clinical trials in the US still not published five years after being finished, scientists write in BMJ
Scientists say about 250,000 people have taken part in unpublished trials and have therefore been exposed to ...
October 28, 2013
[The Guardian] Last week, the BMJ announced that it was finally implementing a practice that it had been discussing since the mid 1990s. Research partly or fully funded by the tobacco industry will no longer be published in BMJ, BMJ Open, Thorax and He...
April 8, 2013
“They’ve started looking at how much money…these companies are making… If you make more than a billion dollars out of a product…somebody’s going to wake up and say… you’ve recouped your R&D…you’ve made an...
April 3, 2013
[Ted Gup, NYTimes] THE news that 11 percent of school-age children now receive a diagnosis of attention deficit hyperactivity disorder — some 6.4 million — gave me a chill. My son David was one of those who received that diagnosis.
In his case, he...
View More Blog Entries
June 21, 2012 1:12 pm
Public health advocates on Wednesday accused the drug company Merck of improperly marketing an over-the-counter allergy medicine directly to children using animated characters from the movie “Madagascar 3: Europe’s Most Wanted.”
June 9, 2012 9:18 pm
After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.
May 9, 2012 10:15 am
Two senior senators said on Tuesday that they had opened an investigation into financial ties between producers of prescription painkillers and pain experts, patient advocacy groups and organizations that set guidelines on how doctors use the drugs.
May 4, 2012 1:35 pm
The FDA-which asked the IOM to “convene a committee to evaluate the scientific and ethical issues involved in conducting studies of the safety of approved drugs”-already collects much of the suggested information, but the data are scattered across multiple records rather than amassed in one central location. “Decentralized records make it difficult for physicians, policy makers and consumers to easily assess information about risks and benefits that accrue over time,” Faden notes.
May 2, 2012 3:38 pm
Next fall, the University of Pennsylvania will host a 10-day crash course in Bioethics in China, which some may argue is an oxymoron. The program will actually take place in Beijing and other cities, and include meetings with academics, policy makers and pharma folks, such as expats who work for large drugmakers. The plan is to not only review some of the hot-button issues – corruption, clinical trials, intellectual property and interactions between physicians and patients – but also delve into cultural differences that shape the way business is done there.
April 25, 2012 11:38 am
Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative. Novartis is taking four NHS areas in the south of England to a judicial review because they have allowed doctors to prescribe the anti-cancer drug Avastin to treat the wet form of age-related macular degeneration.
April 24, 2012 11:23 am
Social media proved to be one powerful tool for a mother dying of breast cancer and desperate to get a drug that has yet to be approved by the U.S. Food and Drug Administration… Gant, 46, posted the video on YouTube as an attempt to plead with the FDA to allow her to use a trial drug known as pertuzumab under compassionate use. The FDA is expected to approve the drug, developed by Genentech, on June 8. But Gant doesn’t expect to live that long.